The immunosuppressive functions of FCRL3 (e.g., restricting T cell activation) may create an inflammatory environment in the tumor microenvironment (TME), thereby indirectly promoting NF-κB-mediated inflammatory signaling. The gene discussed is NFKB1; the disease is neoplasm.